Background and Objectives: Patients with isolated colorectal-cancer-liver-metastases (CRCLM) frequently undergo metastatectomy. Tumor-infiltrating-lymphocytes (TILs)
have prognostic potential in the setting of primary colorectal cancer, however, their role in CRCLM is less studied. We aimed to study the spatial distribution and prognostic role of tumor-infiltrating CD8 + cytotoxic T-cells and FoxP3 + regulatory T-cells at the metastatic site of CRCLM patients.
Methods: TILs were isolated from fresh metastatic tissues of 47 patients with CRCLM.
Archived paraffin-embedded tissue, from the same patients, was retrieved. CD8 + and 
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| INTRODUCTION
Colorectal cancer is a leading cause of cancer death. 1 It is now standard for limited colorectal-cancer-liver metastases (CRCLM) to be considered for resection. 2 While clinical characteristics, such as the clinicalrisk score (CRS), 3 or the resection margin status, 4 can prognosticate patients, the prognostication is far from ideal.
The immune system plays an important role in cancer surveillance and elimination. 5 Tumor infiltrating lymphocytes (TILs) have emerged as potential biomarkers in various cancers. 6 In primary colorectal cancer TILs represent a robust prognostic biomarker that is superior to clinicopathologic characteristics 7, 8 with higher number of TILs associated with improved survival. [9] [10] [11] Naturally, the effect of TILs on prognosis has subsequently been studied in the setting of resected CRCLM. Kito et al 12 showed that the presence of CD8 + TILs in CRCLM was associated with longer tumor doubling times, while Wagner et al 13 showed that TILs isolated from freshly resected CRCLM tumors, and analyzed by flow cytometry, were equally abundant, although more activated, than lymphocytes from the surrounding normal liver tissue.
Moreover, at least four studies have directly related the numbers of TILs in CRCLM to patient prognosis. [14] [15] [16] [17] Halama et al 16 
| Immunohistochemistry
Four micrometre thick sections were cut and mounted on Superfrost 
| Evaluation of immunohistochemistry staining
Stained slides were scanned using NanoZoomer 2.0HT (Hamamatsu 
| TIL isolation and flow-cytometry
Single cell TILs were isolated via tissue digestion as previously 
| Statistical analysis
All analyses were performed in duplicate. Cancer-specific survival and recurrence-free survival were calculated from the date of metastatectomy to the date of event (death from cancer or recurrence of cancer, respectively). Survival curves were estimated by the Kaplan-Meier method. Differences between survival curves were evaluated by the log-rank test. In case of no event patients
were censored at the date of last follow-up. as excluding the two patients who had a CEA>200 ng/mL. The statistical analysis was performed using the SPSS© 21 software.
3 | RESULTS
| Patients and clinicopathologic characteristics
Median time to recurrence was 13.1 months and median survival was 50.9 months. Cancer recurrence occurred in 37/47 patients while 28/47 patients died from colorectal cancer. Baseline characteristics are seen in Table 1 . In univariate analysis only a positive lymph-node status and a high pre-operative CEA value were associated with cancer survival (Table 2A) , while only the preoperative CEA value was associated with cancer recurrence (data not shown).
| CD8 + and FoxP3 + immunohistochemical distribution
The majority of TILs were located in the peri-tumoral areas ( Figure 1 and Figure 2 
| Prognostic value of intra-tumoral and peri-tumoral TILs by immunohistochemistry
Median values were used for cutoffs. Table 2B None of the TIL parameters were predictive of colorectal cancer recurrence.
| Prognostic value of TILs by flow-cytometry
Flow-cytometry on freshly isolated TILs, representing the intra- 
| Multivariate analysis
Multivariate analysis included all known clinicopathologic characteristics and TIL ratios predictive of survival. Both the intra-tumoral CD8 + /FoxP3 + TIL ratio obtained by immunohistochemistry (Table 3) and the CD8 + /Treg TIL ratio obtained by flow-cytometry (Table 4) were independent predictors of colorectal cancer survival. From the clinicopathologic characteristics only lymph node status of the primary tumor and pre-operative CEA values were independent predictors of survival (Tables 3 and 4 ).
| Sensitivity analysis
Excluding the three patients who underwent a second curative intent metastatectomy, as well as excluding the two patients with a pre-operative CEA value at or above 200 ng/mL, led to no significant differences in the multivariate analysis. The intratumoral CD8 + /Treg TIL ratio remained an independent predictor of colorectal cancer survival. We also repeated the multivariate analysis using backward variable selection. We found that the intra-tumoral CD8 + /FoxP3 + TIL ratio, obtained by immunohis- 
| DISCUSSION
We show that the intra-tumoral ratio, but not the peri-tumoral ratio, of This observation is consistent with the hypothesis that the quality matters more than the quantity of the immune infiltrate. including 33 studies and nearly 10 000 patients, showed that lymphocyte ratios and specifically the CD8/FoxP3 ratio, have more prognostic potential than individual lymphocytic subtype densities. 23 In addition, while a lymphocytic infiltrate may be attracted to the margin of the tumor it does not mean that it will lead to tumor disruption. CRCLM may prevent the migration of TILs into the tumor itself, which may be due to chemokine to chemokine receptor mismatch, aberrant microvasculature, cytokine production, a mechanical barrier, or immunosuppression itself. 24 Four prior studies have attempted to examine the prognostic role of TILs in CRCLM. Halama et al 16 examined TIL infiltration on full slides in a 500 μm area from the tumor edge. The area was termed the "invasive margin", which may be similar to what we defined as peritumoral area in our study. In 33 resected patients (68 additional patients had unresectable disease) Halama et al 16 found that high "TIL density" was associated with improved survival. Differences with our study are that Halama et al 16 studied only the area of the peri-tumoral infiltrate (the invasive margin) and "TIL density" was defined as a combination of CD3, CD8, and granzyme B staining.
A study by Katz et al 15 used three 0.6 mm TMA cores per patient, taken from 188 patients with CRCLM. They showed that a high CD8/FoxP3 ratio (or a low FoxP3/CD8 ratio as defined in their study) predicts improved survival following CRCLM resection, a finding that is in agreement with our immunohistochemical findings.
The fact that they used only three small TMA cores means they examined a much smaller area of tumor than in our study but reached a similar conclusion nonetheless. The TMA cores from the Katz et al 15 study likely correspond to the intra-tumoral areas in our study, which may explaining the similarity in our results. Katz et al corresponding primary sites thus is difficult to compare our findings to the study by Lee et al 17 More importantly however, it is unclear where the TMA cores were taken from and no CD8/FoxP3 ratio was reported.
Finally, a more recent study by Nakagawa et al 14 It is clear from the above studies that significant heterogeneity in study design and terminology exists. In fact, differences in methodology, rather than differences in biology, have been hypothesized before to account in differences amongst study observations. 23 In the case of CRCLM, only two prior studies 14, 16 have used full slides, allowing for comparison of intra-tumoral and peri-tumoral TIL populations and none of these studies commented on the possible significance of the CD8/FoxP3 ratio, which we show to be the strongest prognostic marker. On the other hand, the study by Katz et al 15 which found the CD8/FoxP3 ratio to be prognostic of survival, concordant to our immunohistochemical findings, did not examine the peri-tumoral infiltrate. 15 While we validate the findings of Katz et al 15 we show, in addition, that it is indeed the intratumoral infiltrate that matters the most.
A novelty of our study is the validation of our immunohisto- justified, 25 this strategy has its limitations. For example, FoxP3 can in humans, in contrast to mice, also be expressed by activated helper T-cells. 26, 27 In addition, activation-induced FoxP3 in human Teffector cells does not suppress proliferation or cytokine production. 27 Finally, since flow cytometry uses macroscopically resected material, it is virtually impossible to exclude the possibility that some of the peri-tumoral region is present with the tumor sample in some of the cases. On the other hand the distinction of intra-tumoral and peri-tumoral compartments can be accurately made with immunohistochemistry.
No association of immune infiltrate with cancer recurrence was found. However, overall survival likely reflects the biologic behavior of colorectal cancer much better than recurrence. While recurrence is undoubtedly a surrogate of cancer survival, many patients with recurrence still enjoy long term survival, or cure, due to additional interventions. A recurrence may not represent aggressive biologic behavior, but rather metastatic lesions too small to be clinically detected at the time of initial metastatectomy.
While our study has several strengths it also has limitations. The main limitation relates to the sample size of our study, stemming from the need for both prospectively collected flow-cytometric data and retrospectively collected immunohistochemistry data, in the same patients. However, despite our sample size, which is comparable to other similar studies using full slides, and we were able to statistically confirm our a priori generated hypothesis.
| CONCLUSIONS
The ratio of cytotoxic (CD8 + ) to regulatory (FoxP3 + ) T-cells, in the intra-tumoral compartment, but not in the peri-tumoral compartment, can predict survival after resection of CRCLM.
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